Video Experimental Relacionado

Updated: May 29, 2025

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9

Published on: January 3, 2015

La pérdida del complejo SKI hace que los cánceres 9p21.3 eliminados o MSI-H dependen de PELO

Patricia C Borck¹, Isabella Boyle¹, Kristina Jankovic²

¹Broad Institute of MIT and Harvard, Cambridge, MA, USA.

|February 5, 2025

Resumen

Identificamos PELO como un nuevo objetivo letal sintético en cánceres con deleciones 9p21.3 o estado de alta inestabilidad microsatélite (MSI-H). Dirigirse a PELO ofrece una estrategia terapéutica prometedora para estos subtipos específicos de cáncer.

Área de la Ciencia:

La genómica
Biología del cáncer
Letalidad sintética

Sus antecedentes:

Las alteraciones del genoma del cáncer crean vulnerabilidades que se pueden explotar para terapias dirigidas.
Los inhibidores aprobados y en investigación demuestran el potencial de la orientación letal sintética.

Objetivo del estudio:

Para identificar nuevos objetivos letales sintéticos en subtipos específicos de cáncer.
Investigar el papel de PELO en cánceres con deleciones de 9p21.3 o alta inestabilidad microsatélite (MSI-H).

Principales métodos:

Análisis de los datos de detección a gran escala de CRISPR desde el Mapa de Dependencia del Cáncer.
Se ha investigado la dependencia de PELO en cánceres con deleción bialélica 9p21.3 o MSI-H.
Se examinó el impacto del agotamiento de PELO en las respuestas al estrés celular.

Principales resultados:

PELO identificado como un objetivo letal sintético en cánceres con deleción bialélica 9p21.3 (que involucra FOCAD) o MSI-H (que involucra mutaciones TTC37).
Ambos subtipos de cáncer conducen a la desestabilización del complejo super asesino (SKIc).
El agotamiento de PELO en las células SKIc deficientes induce la respuesta proteica desplegada.

Conclusiones:

PELO es un objetivo terapéutico prometedor para cánceres con deleciones bialélicas 9p21.3 o MSI-H con mutaciones TTC37.
La comprensión del papel de PELO en la función SKIc proporciona una base para el desarrollo de terapias dirigidas contra el cáncer.

Más Videos Relacionados

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

Videos de Conceptos Relacionados

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Long-patch Base Excision Repair

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are: